Drug Shortage Report for TEVA-TOLTERODINE

Last updated on 2021-07-22 History
Report ID 93152
Drug Identification Number 02299593
Brand name TEVA-TOLTERODINE
Common or Proper name TOLTERODINE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TOLTERODINE TARTRATE
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-05
Estimated end date 2021-07-31
Actual end date 2021-07-21
Shortage status Resolved
Updated date 2021-07-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-07-22 French Compare
v9 2021-07-22 English Compare
v8 2021-07-15 French Compare
v7 2021-07-15 English Compare
v6 2019-09-12 French Compare
v5 2019-09-12 English Compare
v4 2019-09-06 English Compare
v3 2019-09-05 French Compare
v2 2019-09-05 English Compare
v1 2019-09-05 English Compare

Showing 1 to 10 of 10